NPI: 1831284280 · PASCO, WA 99301 · Critical Access Hospital · NPI assigned 10/03/2006
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| NPI Enumeration Date | 10/03/2006 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 93,166 | $5.27M |
| 2019 | 78,684 | $4.34M |
| 2020 | 62,941 | $3.73M |
| 2021 | 90,882 | $4.80M |
| 2022 | 101,173 | $5.32M |
| 2023 | 98,664 | $5.32M |
| 2024 | 76,410 | $5.16M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 42,470 | 38,636 | $6.68M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 24,361 | 20,737 | $5.62M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12,915 | 11,002 | $5.12M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3,535 | 3,238 | $2.36M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 23,243 | 6,490 | $1.15M |
| 80053 | Comprehensive metabolic panel | 32,534 | 27,543 | $888K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 13,761 | 4,486 | $771K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 35,328 | 29,300 | $602K |
| 70450 | Computed tomography, head or brain; without contrast material | 3,200 | 2,923 | $575K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 13,075 | 11,334 | $518K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5,419 | 5,098 | $485K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 938 | 872 | $481K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 2,897 | 2,766 | $357K |
| G0378 | Hospital observation service, per hour | 865 | 801 | $349K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 5,847 | 1,760 | $285K |
| 71045 | Radiologic examination, chest; single view | 8,220 | 7,271 | $277K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 16,013 | 13,654 | $267K |
| 81001 | 14,753 | 13,364 | $244K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,905 | 1,739 | $237K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 6,086 | 4,996 | $207K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 5,176 | 4,611 | $198K |
| 84484 | 8,707 | 7,079 | $195K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 12,597 | 10,204 | $194K |
| 71046 | Radiologic examination, chest; 2 views | 3,815 | 3,612 | $189K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2,261 | 1,962 | $180K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 962 | 714 | $177K |
| 72125 | Computed tomography, cervical spine; without contrast material | 611 | 570 | $169K |
| 76830 | Ultrasound, transvaginal | 1,538 | 1,479 | $165K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 5,821 | 5,306 | $156K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 4,688 | 4,454 | $149K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2,224 | 2,186 | $142K |
| 83690 | 8,251 | 7,355 | $138K | |
| 36415 | Collection of venous blood by venipuncture | 38,153 | 30,673 | $135K |
| 84443 | Thyroid stimulating hormone (TSH) | 4,575 | 4,336 | $121K |
| 87081 | 3,194 | 3,111 | $105K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3,343 | 1,863 | $103K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 3,858 | 3,328 | $101K |
| 80061 | Lipid panel | 2,947 | 2,868 | $101K |
| 80306 | 2,269 | 2,068 | $100K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2,709 | 2,640 | $97K |
| 81025 | 6,021 | 5,612 | $96K | |
| 87040 | 1,439 | 1,240 | $90K | |
| 74018 | 2,000 | 1,911 | $86K | |
| 86140 | 5,859 | 5,172 | $84K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 188 | 153 | $82K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 110 | 84 | $82K |
| 96375 | Therapeutic injection; each additional sequential IV push | 10,347 | 8,600 | $81K |
| 71250 | 365 | 338 | $77K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 103 | 98 | $74K |
| 83605 | 2,408 | 2,088 | $72K | |
| 94761 | 3,443 | 3,048 | $72K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,724 | 2,638 | $72K |
| 80048 | Basic metabolic panel (calcium, ionized) | 3,765 | 3,224 | $71K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2,125 | 1,766 | $70K |
| 84702 | 1,757 | 1,542 | $68K | |
| 76770 | 368 | 354 | $67K | |
| 83735 | 2,445 | 1,778 | $64K | |
| 87400 | 678 | 654 | $63K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 432 | 415 | $62K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,832 | 1,766 | $53K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2,129 | 2,080 | $52K |
| 73562 | 1,091 | 969 | $51K | |
| 85652 | 4,718 | 4,057 | $49K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 2,810 | 2,404 | $45K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10,752 | 4,703 | $44K |
| 73610 | 973 | 937 | $43K | |
| J3490 | Unclassified drugs | 3,502 | 1,847 | $42K |
| 97162 | 521 | 502 | $40K | |
| 73030 | 962 | 873 | $39K | |
| 81003 | 3,127 | 2,900 | $39K | |
| 80305 | 928 | 852 | $39K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 537 | 324 | $38K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 2,336 | 1,787 | $38K |
| 85610 | 2,867 | 2,349 | $37K | |
| 97014 | 4,556 | 1,582 | $36K | |
| 73130 | 1,267 | 966 | $34K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 949 | 887 | $34K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 77 | 69 | $34K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 270 | 259 | $34K |
| 72100 | 776 | 741 | $32K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 5,452 | 4,416 | $31K |
| 82948 | 3,761 | 2,743 | $31K | |
| 87186 | 1,165 | 1,088 | $30K | |
| 95886 | 774 | 635 | $30K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 581 | 549 | $29K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 579 | 549 | $28K |
| 73630 | 763 | 671 | $26K | |
| 76801 | 186 | 177 | $26K | |
| 83880 | 1,467 | 1,238 | $25K | |
| 84436 | 1,158 | 1,116 | $25K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 44 | 40 | $25K |
| 83550 | 918 | 880 | $25K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2,768 | 2,499 | $24K |
| 86850 | 1,610 | 1,226 | $23K | |
| 85730 | 1,549 | 1,385 | $23K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 3,674 | 841 | $23K |
| 82570 | 508 | 463 | $22K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 8,414 | 6,216 | $22K |
| 96376 | 3,333 | 2,477 | $22K | |
| 86756 | 262 | 258 | $21K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6,094 | 2,662 | $21K |
| 84479 | 1,101 | 1,061 | $20K | |
| S9485 | Crisis intervention mental health services, per diem | 91 | 27 | $20K |
| 94664 | 1,389 | 1,176 | $19K | |
| 97161 | 284 | 260 | $19K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 2,050 | 2,012 | $19K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,029 | 1,833 | $18K |
| 85379 | 730 | 674 | $18K | |
| 83540 | 639 | 619 | $18K | |
| J2704 | Injection, propofol, 10 mg | 2,915 | 2,260 | $17K |
| 12001 | 231 | 217 | $17K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 104 | 102 | $17K |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,186 | 752 | $17K |
| 86003 | 85 | 81 | $16K | |
| 82728 | 767 | 734 | $16K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 45 | 42 | $16K |
| 93041 | 684 | 634 | $15K | |
| 87088 | 990 | 926 | $15K | |
| 88304 | 304 | 278 | $14K | |
| 86900 | 1,961 | 1,555 | $13K | |
| 85027 | 1,190 | 1,149 | $13K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 515 | 477 | $13K |
| 87340 | 407 | 386 | $12K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 353 | 229 | $12K |
| 76641 | 84 | 82 | $11K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 122 | 92 | $11K |
| 85007 | 1,241 | 1,120 | $11K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 3,388 | 2,997 | $11K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 469 | 461 | $11K |
| 73140 | 437 | 430 | $10K | |
| H2036 | Alcohol and/or other drug treatment program, per diem | 91 | 27 | $10K |
| 76642 | 227 | 202 | $10K | |
| 87641 | 350 | 335 | $10K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 3,715 | 2,045 | $9K |
| G0383 | Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | 230 | 212 | $9K |
| 82043 | 306 | 295 | $9K | |
| 86780 | 173 | 170 | $9K | |
| 86901 | 1,960 | 1,554 | $9K | |
| 73110 | 268 | 255 | $8K | |
| 82550 | 512 | 434 | $8K | |
| 82607 | 282 | 265 | $7K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 2,752 | 2,127 | $7K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 2,057 | 1,519 | $7K |
| 87077 | 331 | 319 | $7K | |
| 93971 | 47 | 40 | $6K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 598 | 576 | $6K |
| J2060 | Injection, lorazepam, 2 mg | 2,175 | 1,371 | $6K |
| 82803 | 134 | 105 | $6K | |
| 76870 | 40 | 37 | $6K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 660 | 529 | $5K |
| 73502 | 124 | 112 | $5K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1,790 | 791 | $5K |
| 90715 | 358 | 301 | $5K | |
| 83655 | 319 | 311 | $5K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 29 | 24 | $5K |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 153 | 90 | $5K |
| 95909 | 60 | 54 | $5K | |
| 86480 | 125 | 120 | $4K | |
| 86803 | 78 | 72 | $4K | |
| 87420 | 147 | 133 | $4K | |
| 94060 | 80 | 65 | $4K | |
| 84703 | 255 | 245 | $4K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2,983 | 2,674 | $4K |
| 84439 | 134 | 123 | $4K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,250 | 992 | $3K |
| 72040 | 68 | 66 | $3K | |
| 82746 | 141 | 129 | $3K | |
| 86022 | 14 | 14 | $3K | |
| 72131 | 12 | 12 | $3K | |
| 73120 | 122 | 98 | $3K | |
| 73080 | 66 | 64 | $3K | |
| 76000 | 27 | 26 | $3K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 4,294 | 3,694 | $3K |
| 76536 | 25 | 25 | $3K | |
| 93017 | 24 | 24 | $3K | |
| 99215 | Prolong outpt/office vis | 879 | 308 | $3K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 954 | 705 | $3K |
| 80074 | 63 | 59 | $2K | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 811 | 577 | $2K |
| 95908 | 34 | 25 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 746 | 607 | $2K |
| 80179 | 141 | 125 | $2K | |
| 85008 | 148 | 126 | $2K | |
| 80143 | 138 | 118 | $2K | |
| 97163 | 27 | 26 | $2K | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 213 | 158 | $2K |
| 73560 | 53 | 46 | $2K | |
| 82310 | 242 | 195 | $2K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 15 | 14 | $1K |
| 73620 | 58 | 46 | $1K | |
| J1815 | Injection, insulin, per 5 units | 118 | 67 | $1K |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 137 | 96 | $1K |
| 80047 | 40 | 40 | $980.13 | |
| 97803 | 30 | 25 | $959.53 | |
| 86038 | 44 | 42 | $953.05 | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 409 | 176 | $913.88 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 47 | 40 | $904.30 |
| 86708 | 30 | 27 | $844.13 | |
| 51798 | 85 | 66 | $754.08 | |
| 51702 | 33 | 28 | $724.53 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 223 | 178 | $717.79 |
| 80076 | 19 | 18 | $689.30 | |
| 82248 | 59 | 45 | $671.66 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 88 | 40 | $646.76 |
| 86706 | 30 | 27 | $644.04 | |
| 83516 | 13 | 12 | $608.74 | |
| 36000 | 66 | 64 | $601.50 | |
| J3480 | Injection, potassium chloride, per 2 meq | 21 | 12 | $548.60 |
| 84153 | 13 | 13 | $539.31 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 27 | 25 | $503.75 |
| 29125 | 13 | 12 | $503.44 | |
| 77065 | Tomosynthesis, mammo | 14 | 12 | $445.04 |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 1,604 | 833 | $436.64 |
| 82247 | 37 | 28 | $433.57 | |
| 51701 | 16 | 15 | $428.67 | |
| 87070 | 12 | 12 | $401.82 | |
| 82947 | 23 | 21 | $401.77 | |
| A4565 | Slings | 53 | 53 | $398.17 |
| 82785 | 12 | 12 | $394.96 | |
| 87205 | 27 | 25 | $380.56 | |
| 86709 | 13 | 12 | $373.73 | |
| 86704 | 15 | 14 | $292.42 | |
| 99205 | Prolong outpt/office vis | 121 | 42 | $256.10 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 19 | 14 | $253.26 |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | 247 | 238 | $247.00 |
| 97016 | 42 | 15 | $230.44 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 69 | 39 | $223.39 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 12 | 12 | $177.22 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 35 | 15 | $171.55 |
| A4556 | Electrodes, (e.g., apnea monitor), per pair | 216 | 201 | $168.90 |
| 0002A | 21 | 21 | $144.54 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 15 | 14 | $108.66 |
| 87581 | 15 | 14 | $108.66 | |
| 87486 | 15 | 14 | $108.66 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 47 | 40 | $107.01 |
| 0001A | 13 | 13 | $96.76 | |
| 84403 | 13 | 12 | $95.20 | |
| A9270 | Non-covered item or service | 6,316 | 4,283 | $64.07 |
| 90656 | 23 | 20 | $60.59 | |
| 80320 | 1,007 | 903 | $60.32 | |
| J1940 | Injection, furosemide, up to 20 mg | 35 | 28 | $51.28 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 21 | 15 | $45.66 |
| 81002 | 238 | 203 | $34.12 | |
| 96127 | 81 | 64 | $20.05 | |
| 3077F | 57 | 45 | $0.00 | |
| 91300 | 34 | 22 | $0.00 | |
| 1160F | 983 | 810 | $0.00 | |
| 3725F | 411 | 365 | $0.00 | |
| 3078F | 634 | 545 | $0.00 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 43 | 40 | $0.00 |
| 0502F | 13 | 12 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 93 | 83 | $0.00 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 720 | 165 | $0.00 |
| 80329 | 524 | 479 | $0.00 | |
| 1125F | 251 | 211 | $0.00 | |
| 1036F | 789 | 664 | $0.00 | |
| 3074F | 526 | 449 | $0.00 | |
| 3008F | 874 | 729 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 14 | 14 | $0.00 |
| 3079F | 59 | 50 | $0.00 | |
| 1126F | 310 | 246 | $0.00 | |
| 3075F | 13 | 13 | $0.00 |